Researchers from Oxford University have worked with AstraZeneca on a potential coronavirus vaccine. Photo: EPA-EFE
Coronavirus: AstraZeneca-Oxford vaccine ‘offers up to 90 per cent’ protection in trials
- Vaccine candidate appears to reduce transmission of asymptomatic infections and can be easily stored and distributed
- Smaller dose of drug seems to be more effective but more investigation needed, developers say
Topic |
Coronavirus pandemic
Researchers from Oxford University have worked with AstraZeneca on a potential coronavirus vaccine. Photo: EPA-EFE